Companies by Sector - Pharmaceuticals and Biotechnology
| EPIC | Company | Index | Dividend Yield | Market Cap | Price Close | % Change |
|---|---|---|---|---|---|---|
| GUN | Gunsynd | AIM | £1.4M | 0.09 | 9.50% | |
| VAL | ValiRx | AIM | £2.3M | 0.29 | -2.20% | |
| TRX | Tissue Regenix Group | AIM | £5.16M | 7.25 | -1.50% | |
| PRM | Proteome Sciences | AIM | £6.05M | 1.56 | 8.00% | |
| OPTI | OptiBiotix Health | AIM | £6.61M | 6.25 | -3.30% | |
| FUM | Futura Medical | AIM | £6.98M | 1.14 | 14.60% | |
| IXI | Ixico | AIM | £7.23M | 7.60 | -1.50% | |
| AGL | Angle | AIM | £7.72M | 2.40 | -0.70% | |
| VRCI | Verici Dx | AIM | £8.7M | 0.56 | -4.80% | |
| CEL | Celadon Pharmaceuticals | AIM | £9.23M | 13.40 | % | |
| OBD | Oxford BioDynamics | AIM | £10.38M | 0.24 | -4.00% | |
| GDR | Genedrive | AIM | £11.17M | 1.05 | -1.60% | |
| EDEN | Eden Research | AIM | £19.63M | 3.20 | -2.40% | |
| SAR | Sareum Holdings | AIM | £21.4M | 16.00 | -5.60% | |
| AREC | Arecor Therapeutics | AIM | £27.18M | 70.00 | -1.30% | |
| IMM | ImmuPharma | AIM | £27.2M | 4.96 | -3.00% | |
| SBTX | SkinBioTherapeutics | AIM | £27.21M | 9.27 | -14.90% | |
| POLB | Poolbeg Pharma | AIM | £29.97M | 4.10 | -2.10% | |
| ABDX | Abingdon Health | AIM | £34.67M | 7.80 | 2.60% | |
| FARN | Faron Pharmaceuticals OY | AIM | £52.68M | 43.25 | 1.10% | |
| HVO | Hvivo | AIM | 2.53 | £53.75M | 8.00 | -5.10% |
| OBI | Ondine Biomedical Inc | AIM | £57.15M | 11.50 | 2.60% | |
| EAH | Eco Animal Health Group | AIM | £65.39M | 96.50 | -4.30% | |
| ANIC | Agronomics | AIM | £73.96M | 6.80 | -0.60% | |
| BVXP | Bioventix | AIM | 10.34 | £75.76M | 1,488.00 | -2.20% |
| 4BB | 4basebio | AIM | £80.48M | 550.00 | -0.40% | |
| STX | Shield Therapeutics | AIM | £88.14M | 8.30 | -7.90% | |
| ANP | Anpario | Main Market | 2.51 | £95.26M | 466.80 | -0.90% |
| DXRX | Diaceutics | AIM | £123.98M | 144.00 | -0.50% | |
| SCLP | Scancell Holdings | AIM | £132.32M | 12.30 | -1.10% | |
| BMK | Benchmark Holdings | AIM | £135.69M | 22.05 | 1.50% | |
| MXCT | Maxcyte Inc | AIM | £161.75M | 147.69 | -1.20% | |
| ANCR | Animalcare Group | AIM | 1.97 | £182.28M | 261.00 | -2.60% |
| BTG | BTG | AIM | 3.73 | £189.9M | 117.64 | -0.10% |
| PRTC | Puretech Health | FTSE Small Cap | £293.63M | 118.40 | -1.99% | |
| AVCT | Avacta Group | AIM | £301.81M | 69.00 | -7.00% | |
| AGY | Allergy Therapeutics | AIM | £633.25M | 10.40 | -2.50% | |
| OXB | Oxford BioMedica | FTSE Small Cap | £769.96M | 644.00 | 1.10% | |
| INDV | Indivior | FTSE 250 | £1.54B | 1,238.00 | -3.10% | |
| GNS | Genus | FTSE 250 | 1.20 | £1.78B | 2,665.00 | -0.37% |
| HCM | Hutchmed China | AIM | £1.84B | 215.00 | 4.80% | |
| HIK | Hikma Pharmaceuticals | FTSE 100 | 4.89 | £2.83B | 1,285.00 | -0.23% |
| HLN | Haleon | FTSE 100 | 1.80 | £35.18B | 386.20 | -2.23% |
| GSK | GSK | FTSE 100 | 3.58 | £81.84B | 1,972.50 | -2.01% |
| AZN | AstraZeneca | FTSE 100 | 1.64 | £223.37B | 14,276.00 | -0.87% |